Xiuzhi Duan

732 total citations
33 papers, 526 citations indexed

About

Xiuzhi Duan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Xiuzhi Duan has authored 33 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Pulmonary and Respiratory Medicine and 12 papers in Cancer Research. Recurrent topics in Xiuzhi Duan's work include Prostate Cancer Treatment and Research (12 papers), Cancer, Lipids, and Metabolism (6 papers) and Biosensors and Analytical Detection (5 papers). Xiuzhi Duan is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), Cancer, Lipids, and Metabolism (6 papers) and Biosensors and Analytical Detection (5 papers). Xiuzhi Duan collaborates with scholars based in China and United States. Xiuzhi Duan's co-authors include Zhihua Tao, Weiwei Liu, Yu Pan, Xuchu Wang, Chunhua Liu, Binbin Yin, Yuhua Chen, Yiyun Wang, Yibei Dai and Ping Ying and has published in prestigious journals such as Journal of Clinical Oncology, Small and British Journal of Cancer.

In The Last Decade

Xiuzhi Duan

31 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiuzhi Duan China 13 264 130 109 103 99 33 526
Jianwen Zhang China 16 382 1.4× 227 1.7× 69 0.6× 56 0.5× 140 1.4× 27 641
Si Yang China 17 455 1.7× 206 1.6× 109 1.0× 49 0.5× 95 1.0× 43 702
Jin Gong China 16 306 1.2× 127 1.0× 46 0.4× 125 1.2× 121 1.2× 41 587
Fenghua Lan China 15 384 1.5× 137 1.1× 123 1.1× 40 0.4× 110 1.1× 62 712
Mélanie Lambert France 14 456 1.7× 126 1.0× 126 1.2× 41 0.4× 148 1.5× 28 802
Yan-qing Ding China 18 456 1.7× 172 1.3× 52 0.5× 77 0.7× 188 1.9× 71 747
Andrew Trotta Australia 13 453 1.7× 154 1.2× 122 1.1× 55 0.5× 125 1.3× 17 693
Longzhen Piao China 17 450 1.7× 126 1.0× 45 0.4× 57 0.6× 181 1.8× 33 674

Countries citing papers authored by Xiuzhi Duan

Since Specialization
Citations

This map shows the geographic impact of Xiuzhi Duan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiuzhi Duan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiuzhi Duan more than expected).

Fields of papers citing papers by Xiuzhi Duan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiuzhi Duan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiuzhi Duan. The network helps show where Xiuzhi Duan may publish in the future.

Co-authorship network of co-authors of Xiuzhi Duan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiuzhi Duan. A scholar is included among the top collaborators of Xiuzhi Duan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiuzhi Duan. Xiuzhi Duan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gu, Hua, et al.. (2025). Identifying the genetic link between type 1 diabetes and autoimmune liver diseases. Clinical and Experimental Hepatology. 11(1). 52–60.
2.
Wang, Weixi, Chunhua Liu, Tao Sun, et al.. (2023). Exosomal miR‐222‐3p contributes to castration‐resistant prostate cancer by activating mTOR signaling. Cancer Science. 114(11). 4252–4269. 14 indexed citations
3.
Wang, Xuchu, Tao Chen, Ping Ying, et al.. (2023). Sequence‐Guided Localization of DNA Hybridization Enables Highly Selective and Robust Genotyping. Small. 20(20). e2307985–e2307985. 2 indexed citations
4.
Zhang, Zhengliang, Weixi Wang, Chunhua Liu, et al.. (2023). New insights into lipid metabolism and prostate cancer (Review). International Journal of Oncology. 62(6). 11 indexed citations
5.
Duan, Xiuzhi, Xuchu Wang, Ping Ying, et al.. (2023). How to better select SARS‐CoV‐2 preservation solution of virus nucleic acid testing. Journal of Clinical Laboratory Analysis. 37(15-16). e24956–e24956. 1 indexed citations
6.
Zhang, Lingyu, Zhengliang Zhang, Yiwen Sang, et al.. (2022). Emerging Proteins in CRPC: Functional Roles and Clinical Implications. Frontiers in Oncology. 12. 873876–873876. 5 indexed citations
7.
Pan, Yu, Yibei Dai, Tingting Zhuang, et al.. (2022). Identification and Validation of Three Hub Genes Involved in Cell Proliferation and Prognosis of Castration‐Resistant Prostate Cancer. Oxidative Medicine and Cellular Longevity. 2022(1). 8761112–8761112. 2 indexed citations
8.
Sang, Yiwen, Shizhen Zhang, Lingyu Zhang, et al.. (2021). SGK1 in Human Cancer: Emerging Roles and Mechanisms. Frontiers in Oncology. 10. 608722–608722. 56 indexed citations
9.
Liu, Chunhua, et al.. (2021). The MYH9 Cytoskeletal Protein Is a Novel Corepressor of Androgen Receptors. Frontiers in Oncology. 11. 641496–641496. 2 indexed citations
10.
Zhuang, Tingting, Ping Ying, Yingzhi Zhang, et al.. (2021). Elevated systemic immune inflammation index level is associated with disease activity in ulcerative colitis patients. Clinica Chimica Acta. 517. 122–126. 48 indexed citations
11.
Duan, Xiuzhi, et al.. (2021). PCN109 Disease Burden of Metastatic Hormone-Sensitive Prostate Cancer (MHSPC) in China. Value in Health. 24. S39–S40. 1 indexed citations
12.
Duan, Xiuzhi, Xuchu Wang, Yu Pan, et al.. (2020). Effect of virus inactivation on weak positive results of nucleic acid test for 2019 novel coronavirus. Zhonghua jianyan yixue zazhi. 43(4). 358–363. 4 indexed citations
13.
Duan, Xiuzhi, Xiaoming Xu, Binbin Yin, et al.. (2019). The prognosis value of EphA3 and the androgen receptor in prostate cancer treated with radical prostatectomy. Journal of Clinical Laboratory Analysis. 33(5). e22871–e22871. 8 indexed citations
14.
Yin, Binbin, Weiwei Liu, Yu Pan, et al.. (2017). Association between human papillomavirus and prostate cancer: A meta-analysis. Oncology Letters. 14(2). 1855–1865. 27 indexed citations
15.
Pan, Yu, Xiuzhi Duan, Yue Cheng, et al.. (2017). Androgen-independent LNCaP cells are a subline of LNCaP cells with a more aggressive phenotype and androgen suppresses their growth by inducing cell cycle arrest at the G1 phase. International Journal of Molecular Medicine. 40(5). 1426–1434. 28 indexed citations
16.
Liu, Weiwei, Binbin Yin, Xuchu Wang, et al.. (2017). Circulating tumor cells in prostate cancer: Precision diagnosis and therapy. Oncology Letters. 14(2). 1223–1232. 27 indexed citations
17.
Wang, Xuchu, Weiwei Liu, Binbin Yin, et al.. (2016). Colorimetric detection of gene transcript by target-induced three-way junction formation. Talanta. 158. 1–5. 5 indexed citations
18.
Cheng, Yue, Yu Pan, Xiuzhi Duan, et al.. (2015). Genome-wide analysis of androgen receptor binding sites in prostate cancer cells. Experimental and Therapeutic Medicine. 9(6). 2319–2324. 17 indexed citations
19.
Duan, Xiuzhi. (2015). The progress of biomarkers in prostate cancer. Zhonghua jianyan yixue zazhi. 38(10). 657–660. 1 indexed citations
20.
Goyal, Amit, et al.. (2006). Breast cancer metastatic to the colon 20 years after bilateral mastectomy. Endoscopy. 38(S 2). E1–E1. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026